纳尔德美丁对阿片类药物引起的便秘的安全性 - - 系统性审查和元分析
Bastian Wobbe1, Maximilian Gerner2, Claus-Henning Köhne1
1Department of Oncology and Hematology, Klinikum Oldenburg AoR, Oldenburg, Lower Saxony, Germany.
Journal of pain & palliative care pharmacotherapy
|December 19, 2024
概括
纳尔德美丁对于阿片类药物诱导的便秘是安全的,具有可控的胃肠道副作用. 癌症患者经历了更多不良事件,需要进一步研究以确保安全使用.
科学领域:
- 胃肠病学 胃肠病学
- 药理学 药理学是指药理学的学科.
- 在瘤学瘤学.
背景情况:
- 纳尔德美丁是一种μ-阿片类受体对抗剂,用于阿片类药物诱导的便秘 (OIC).
- 对副作用的担忧,如阿片类药物戒断,限制了其使用,特别是在癌症患者中.
- 评估纳尔德美丁的安全概况对于优化OIC管理至关重要.
研究的目的:
- 系统地审查和分析纳尔德美丁用于治疗OIC的安全数据.
- 评估接受纳尔德美丁的患者发生不良事件的风险,包括阿片类药物戒断.
- 专门评估癌症患者亚组中的安全性.
主要方法:
- 按照PRISMA指南进行系统审查和元分析.
- 搜索了PubMed和Cochrane图书馆的相关研究,直到2024年4月16日.
- 将纳尔德美丁治疗组与安慰剂控制组进行了比较.
主要成果:
- 与安慰剂相比,治疗出现的不良事件 (OR=1.06) 或严重不良事件 (OR=1.02) 没有显著差异.
- 没有观察到阿片类药物戒断的风险增加.
- 胃肠道疾病的风险增加,特别是腹 (OR=2.44) 和腹痛 (OR=3.31).
- 癌症小组显示出更高的治疗出现和严重不良事件,但没有增加阿片类药物戒断风险.
结论:
- 纳尔德美丁证明了OIC治疗的整体安全性,具有可控的胃肠道副作用.
- 胃肠道不良事件的发生率增加,如腹和腹痛是值得注意的.
- 癌症患者中较高的不良事件发生率需要进一步调查,以确保在这个人群中安全有效地使用.
相关概念视频
Drugs Affecting GI Tract Motility: Opioids as Antidiarrheal Agents
174
Diarrhea, a condition marked by frequent loose or watery bowel movements, can be triggered by multiple factors such as viral or bacterial infections, food intolerances, anxiety, medications, and digestive disorders. Symptoms may include abdominal pain, bloating, nausea, and cramping. Severe or prolonged diarrhea can lead to complications like electrolyte imbalances, malnutrition, and dehydration if left untreated.
Opioids, widely used antidiarrheal agents, mitigate diarrhea by slowing down...
Opioids, widely used antidiarrheal agents, mitigate diarrhea by slowing down...
174
Drugs for Treatment of Constipation-Predominant IBS
133
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
133
Drugs for Treatment of Diarrhea-Predominant IBS
147
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
147
Opioid Analgesics: Synthetic and Semisynthetic Opioids
219
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
219
Analgesia and Pain Management
496
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
496
Drugs Affecting GI Tract Motility: Other Laxatives
166
Laxatives are primarily used to alleviate constipation, a common gastrointestinal disorder characterized by infrequent bowel movements and difficulty passing stools. They work by various mechanisms to increase the volume or frequency of bowel movements. The primary modes of action of laxatives include increasing stool bulk, softening the stool, stimulating intestinal motility, and osmotically drawing water into the intestines.
Osmotic or saline laxatives, like magnesium hydroxide or milk of...
Osmotic or saline laxatives, like magnesium hydroxide or milk of...
166


